Skip to main content
. 2002 Sep;40(9):3209–3218. doi: 10.1128/JCM.40.9.3209-3218.2002

TABLE 2.

Profiles of the 11 patients with HEV viremia

Patient no. Age (yr)/sexa Locationb Yr of onset Peak T. Bil (mg/dl)c Peak ALT (IU/liter)d Peak AST (IU/liter)e OD at 450 nmf
Name of HEV isolate HEV genotype
IgM-class anti-HEV IgG-class anti-HEV
1 55/M Hokkaido 1997 4.2 4,850 3,680 2.105 >3.000 HE-JA1 IV
2 71/M Hokkaido 1998 6.2 4,623 5,931 2.665 >3.000 HE-JA2 IV
3 42/M Hokkaido 1998 24.0 1,744 1,255 >3.000 >3.000 HE-JA3 IV
4 44/M Hokkaido 2000 9.7 1,562 1,385 >3.000 2.660 HE-JA4 III
5 46/M Iwate 1998 4.1 2,824 1,624 2.255 >3.000 HE-JA5 III
6 47/F Iwate 1999 0.8 1,430 1,415 >3.000 >3.000 HE-JA6 III
7 72/M Iwate 2001 20.0 914 1,050 >3.000 >3.000 HE-JA7 III
8 56/M Iwate 2001 5.7 2,066 539 >3.000 >3.000 HE-JA8 III
9 45/M Fukushima 2001 1.5 2,290 1,191 >3.000 >3.000 HE-JA9 III
10 40/F Tokyo 1993 2.4 1,019 590 >3.000 >3.000 HE-JA10 III
11 50/M Yamanashi 2001 19.2 1,886 877 1.638 >3.000 HE-JA11 III
a

M, male; F, female.

b

Arranged from north to south in Japan.

c

T. Bil., total bilirubin (normal range, 0.2 to 1.0 mg/dl).

d

Normal range, 4 to 30 IU/liter.

e

Normal range, 11 to 30 IU/liter.

f

Detected at admission.